Glaring need for new studies of antidepressants in cancer care

Research output: Contribution to journalEditorialResearchpeer-review


A small number of older studies have demonstrated efficacy for a few antidepressants in cancer care ? namely, mianserin, fluoxetine and paroxetine ? but we lack an evidence base for most of the currently used antidepressants. In their systematic review and meta-analysis in this issue of the role of antidepressants in the treatment of cancer-related depression, Riblet et al. [1] call for high-quality randomized clinical trials that properly examine the efficacy, tolerability and safety of modern-day antidepressants.
Original languageEnglish
Pages (from-to)553 - 554
Number of pages2
JournalGeneral Hospital Psychiatry
Issue number6
Publication statusPublished - 2014

Cite this